The Growing Threat of Late HIV Diagnoses in Europe: A Call for Innovation
The European Centre for Disease Prevention and Control (ECDC) has issued a stark warning about the persistent issue of delayed HIV diagnoses, which poses a significant challenge to public health. According to their report, this silent threat is hindering the timely administration of antiretroviral therapy and increasing the risk of AIDS.
"We need to revolutionize our testing strategies and empower individuals to take charge of their health through self-testing," emphasized Pamela Rendi-Wagner, the agency director. This call to action highlights the urgency of the situation.
In Greece, a concerning trend emerged: over 50% of individuals diagnosed with HIV in 2025 did so at a late stage, despite the availability of effective treatments that can transform HIV into a manageable chronic condition. This delay in diagnosis has far-reaching consequences.
Since the onset of the pandemic, Greece has recorded a total of 21,815 HIV cases, including 4,795 AIDS diagnoses and 3,721 deaths. This year, 11,549 individuals received life-saving antiretroviral therapy. However, the numbers tell a different story when it comes to new diagnoses. As of October, 526 new HIV cases were reported, with a staggering 52% classified as late-stage infections.
The Greek Health Authority, known as EODY, also shared encouraging progress towards the UNAIDS 95-95-95 goals. In 2024, they achieved 91% of diagnosed cases, 73% of treated cases, and 94% of individuals successfully suppressed the virus. However, the ECDC paints a different picture for Europe as a whole, describing a hidden HIV crisis where 54% of diagnoses in 2024 were made at a late stage.
This alarming statistic underscores the need for innovative strategies in testing and community engagement to address the issue of delayed diagnoses and ultimately improve HIV management across Europe.
